Tanshinone IIA can inhibit human pancreatic carcinoma BxPC3 cells through decreasing the protein expressions of IGFR, EGFR, VEGFR and blocking both Ras/Raf/MEK/ERK and Ras/PI3K/AKT/mTOR pathway in vitro and in vivo

被引:0
|
作者
Su, C. C. [1 ]
机构
[1] Changua Christian Hosp, Changhua, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-021
引用
收藏
页码:7 / 7
页数:1
相关论文
共 29 条
  • [21] Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways
    Cui, Shu-Xiang
    Shi, Wen-Na
    Song, Zhi-Yu
    Wang, Shu-Qing
    Yu, Xin-Feng
    Gao, Zu-Hua
    Qu, Xian-Jun
    ONCOTARGET, 2016, 7 (24) : 36767 - 36782
  • [22] Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2
    Soares, Heloisa P.
    Ming, Ming
    Mellon, Michelle
    Young, Steven H.
    Han, Liang
    Sinnet-Smith, James
    Rozengurt, Enrique
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (04) : 1014 - 1023
  • [23] Inhibition of PI3K/AKT/mTOR pathway in human melanoma cells with induction of autophagy and decreased tumor growth both in vitro and in vivo by a dietary flavonoid fisetin
    Syed, D. N.
    Adhami, V. M.
    Chamcheu, J.
    Mukhtar, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S24 - S24
  • [24] Dual PI3K/mTOR Inhibitors Induce Rapid Over-Activation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells Through Suppression of mTORC2
    Soares, H. P.
    Xu, Q.
    Young, S. H.
    Sinnet-Smith, J.
    Rozengurt, E.
    PANCREAS, 2015, 44 (08) : 1416 - 1416
  • [25] Dual PI3K/mTOR Inhibitors Induce Rapid Over-Activation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells Through Suppression of mTORC2
    Soares, Heloisa P.
    Ming, Ming
    Young, Steven H.
    Sinnett-Smith, James
    Rozengurt, Enrique
    GASTROENTEROLOGY, 2015, 148 (04) : S949 - S950
  • [26] Theabrownins Produced via Chemical Oxidation of Tea Polyphenols Inhibit Human Lung Cancer Cells in vivo and in vitro by Suppressing the PI3K/AKT/mTOR Pathway Activation and Promoting Autophagy
    Wang, Yongyong
    Yuan, Yao
    Wang, Chunpeng
    Wang, Bingjie
    Zou, Wenbin
    Zhang, Ni
    Chen, Xiaoqiang
    FRONTIERS IN NUTRITION, 2022, 9
  • [27] Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties
    McCubrey, James A.
    Meher, Akshaya K.
    Akula, Shaw M.
    Abrams, Stephen L.
    Steelman, Linda S.
    LaHair, Michelle M.
    Franklin, Richard A.
    Martelli, Alberto M.
    Ratti, Stefano
    Cocco, Lucio
    Barbaro, Fulvio
    Duda, Przemyslaw
    Gizak, Agnieszka
    AGING-US, 2022, 14 (08): : 3365 - 3386
  • [28] Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models
    Schrauwen, Stefanie
    Depreeuw, Jeroen
    Coenegrachts, Lieve
    Hermans, Els
    Lambrechts, Diether
    Amant, Frederic
    GYNECOLOGIC ONCOLOGY, 2015, 138 (01) : 165 - 173
  • [29] Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC 1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
    Chen, Min
    Lu, Jian
    Wei, Wei
    Lv, Ying
    Zhang, Xiaoqi
    Yao, Yuling
    Wang, Lei
    Ling, Tingsheng
    Zou, Xiaoping
    ONCOTARGETS AND THERAPY, 2018, 11 : 6705 - 6722